Patients’ Experiences and Communication with Teledermatology versus Face-to-Face Dermatology
Abstract
:1. Introduction
2. Materials and Methods
2.1. Design
2.2. Participants and Setting
2.3. Measures and Instruments
2.4. Procedure
- I.
- The patient went to the consultation of his or her Primary Care Physician (PCP) for a skin affliction, the PCP completed the teleconsultation form in the digital platform “Telederma,” indicating the affliction’s characteristics, localization, previous treatment (if any), background, etc. Afterwards, the PCP could directly give an appointment for the TD consultation or the patient could request it at the admissions desk at the primary health center;
- II.
- In a period under 10 working days, the patient attends the TD appointment in his or her primary care center. Upon entering, the nurse asks for the signed informed consent form that the PCP previously provided (the consent form is a document created by the Ministry of Health and Families from the Junta of Andalusia, through which the patient agrees to be attended telematically). Afterwards, the same nurse verifies that all the information needed by the dermatologist is correct, after which the images are taken using a set sequence according to the protocol, for their correct viewing. Independently of each of the lesions, a panoramic image is taken at a distance of at least 1 m in which the anatomical area is viewed clearly and posteriorly images with polarized light are taken with a dermatoscope; whenever possible, a measurement scale is used to determine the size of the lesion if a follow-up is needed. Then, the images are uploaded to the platform (one by one). On the upper part of the image, there is an “observations” section in which the incidences or observations can be described in detail, which could be useful for the dermatologist specialist at the hospital. Lastly, the images are eliminated from the camera before continuing with the next patient;
- III.
- In a period of a week, the patient goes back to his or her PCP to collect the results along with the diagnosis, treatment, and the indications deemed appropriate by the dermatologist, although if a severe pathology is suspected, the times are reduced to 1–2 days or less than 24 h.
2.5. Ethical Consideractions
2.6. Statistical Analysis
3. Results
3.1. Patient Baseline Characteristics
3.2. Patients’ Experiences and Communication
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hay, R.J.; Johns, N.E.; Williams, H.C.; Bolliger, I.W.; Dellavalle, R.P.; Margolis, D.J.; Marks, R.; Naldi, L.; Weinstock, M.A.; Wulf, S.K.; et al. The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions. J. Investig. Dermatol. 2014, 134, 1527–1534. [Google Scholar] [CrossRef] [PubMed]
- Hay, R.J.; Augustin, M.; Griffiths, C.E.M.; Sterry, W.; Board of the International League of Dermatological Societies and the Grand Challenges Consultation Groups. The Global Challenge for Skin Health. Br. J. Dermatol. 2015, 172, 1469–1472. [Google Scholar] [CrossRef] [PubMed]
- Tizek, L.; Schielein, M.C.; Seifert, F.; Biedermann, T.; Böhner, A.; Zink, A. Skin Diseases Are More Common than We Think: Screening Results of an Unreferred Population at the Munich Oktoberfest. J. Eur. Acad. Dermatol. Venereol. 2019, 33, 1421–1428. [Google Scholar] [CrossRef] [PubMed]
- Flohr, C.; Hay, R. Putting the Burden of Skin Diseases on the Global Map. Br. J. Dermatol. 2021, 184, 189–190. [Google Scholar] [CrossRef]
- McKoy, K.; Halpern, S.; Mutyambizi, K. International Teledermatology Review. Curr. Dermatol. Rep. 2021, 10, 55–66. [Google Scholar] [CrossRef]
- Pasquali, P.; Romero-Aguilera, G.; Moreno-Ramírez, D. Teledermatología En Tiempos de Pandemia: El Antes, El Durante y El Después. Actas Dermosifiliogr. 2021, 112, 324–329. [Google Scholar] [CrossRef]
- Fortugno, A.P.; Dellavalle, R.P. Implementation of a Patient-Assisted Teledermatology Model in the Veteran Health Administration. Dermatol. Online J. 2019, 25, 3. [Google Scholar] [CrossRef]
- Coates, S.J.; Kvedar, J.; Granstein, R.D. Teledermatology: From Historical Perspective to Emerging Techniques of the Modern Era: Part I: History, Rationale, and Current Practice. J. Am. Acad. Dermatol. 2015, 72, 563–574. [Google Scholar] [CrossRef]
- Abbott, L.M.; Magnusson, R.S.; Gibbs, E.; Smith, S.D. Smartphone Use in Dermatology for Clinical Photography and Consultation: Current Practice and the Law. Australas. J. Dermatol. 2018, 59, 101–107. [Google Scholar] [CrossRef]
- Ouellette, S.; Rao, B.K. Usefulness of Smartphones in Dermatology: A US-Based Review. Int. J. Environ. Res. Public. Health 2022, 19, 3553. [Google Scholar] [CrossRef]
- Elsner, P. Teledermatology in the Times of COVID-19—A Systematic Review. J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. 2020, 18, 841–845. [Google Scholar] [CrossRef] [PubMed]
- Nazzaro, G.; Marzano, A.V.; Berti, E. What Is the Role of a Dermatologist in the Battle against COVID-19? The Experience from a Hospital on the Frontline in Milan. Int. J. Dermatol. 2020, 59, e238–e239. [Google Scholar] [CrossRef] [PubMed]
- Trepanowski, N.; Chang, M.S.; Zhou, G.; Ahmad, M.; Berry, E.G.; Bui, K.; Butler, W.H.; Chu, E.Y.; Curiel-Lewandrowski, C.; Dellalana, L.E.; et al. Delays in Melanoma Presentation during the COVID-19 Pandemic: A Nationwide Multi-Institutional Cohort Study. J. Am. Acad. Dermatol. 2022, in press. [Google Scholar] [CrossRef] [PubMed]
- Romero, G.; de Argila, D.; Ferrandiz, L.; Sánchez, M.P.; Vañó, S.; Taberner, R.; Pasquali, P.; de la Torre, C.; Alfageme, F.; Malvehy, J.; et al. Practice Models in Teledermatology in Spain: Longitudinal Study, 2009-2014. Actas Dermosifiliogr. 2018, 109, 624–630. [Google Scholar] [CrossRef]
- Andrees, V.; Klein, T.M.; Augustin, M.; Otten, M. Live Interactive Teledermatology Compared to In-Person Care—A Systematic Review. J. Eur. Acad. Dermatol. Venereol. 2020, 34, 733–745. [Google Scholar] [CrossRef]
- Romero, G.; Sánchez, P.; García, M.; Cortina, P.; Vera, E.; Garrido, J.A. Randomized Controlled Trial Comparing Store-and-Forward Teledermatology Alone and in Combination with Web-Camera Videoconferencing. Clin. Exp. Dermatol. 2010, 35, 311–317. [Google Scholar] [CrossRef]
- Ayén-Rodriguez, A.; Llamas-Molina, J.M.; Cabrerizo-Carvajal, A.M.; Leon-Lopez, F.J.; Ruiz-Villaverde, R. Teledermatology in the Health Center West Area of Granada: From primary to specialized care. Semergen 2021, 47, 224–229. [Google Scholar] [CrossRef]
- Marchell, R.; Locatis, C.; Burgess, G.; Maisiak, R.; Liu, W.-L.; Ackerman, M. Patient and Provider Satisfaction with Teledermatology. Telemed. J. e-Health Off. J. Am. Telemed. Assoc. 2017, 23, 684–690. [Google Scholar] [CrossRef]
- Mounessa, J.S.; Chapman, S.; Braunberger, T.; Qin, R.; Lipoff, J.B.; Dellavalle, R.P.; Dunnick, C.A. A Systematic Review of Satisfaction with Teledermatology. J. Telemed. Telecare 2018, 24, 263–270. [Google Scholar] [CrossRef]
- López-Liria, R.; Valverde-Martínez, M.Á.; López-Villegas, A.; Bautista-Mesa, R.J.; Vega-Ramírez, F.A.; Peiró, S.; Leal-Costa, C. Teledermatology versus Face-to-Face Dermatology: An Analysis of Cost-Effectiveness from Eight Studies from Europe and the United States. Int. J. Environ. Res. Public. Health 2022, 19, 2534. [Google Scholar] [CrossRef]
- Hadeler, E.; Gitlow, H.; Nouri, K. Definitions, Survey Methods, and Findings of Patient Satisfaction Studies in Teledermatology: A Systematic Review. Arch. Dermatol. Res. 2021, 313, 205–215. [Google Scholar] [CrossRef] [PubMed]
- Kaunitz, G.; Yin, L.; Nagler, A.R.; Sicco, K.L.; Kim, R.H. Assessing Patient Satisfaction with Live-Interactive Teledermatology Visits During the COVID-19 Pandemic: A Survey Study. Telemed. J. e-Health Off. J. Am. Telemed. Assoc. 2022, 28, 591–596. [Google Scholar] [CrossRef] [PubMed]
- Coleman, C. Health Literacy and Clear Communication Best Practices for Telemedicine. HLRP Health Lit. Res. Pract. 2020, 4, e224–e229. [Google Scholar] [CrossRef]
- Sjetne, I.S.; Bjertnaes, O.A.; Olsen, R.V.; Iversen, H.H.; Bukholm, G. The Generic Short Patient Experiences Questionnaire (GS-PEQ): Identification of Core Items from a Survey in Norway. BMC Health Serv. Res. 2011, 11, 88. [Google Scholar] [CrossRef] [PubMed]
- Leal Costa, C.; Gómez Sánchez, R.; Tirado González, S.; Rodríguez Marín, J.; van-der Hofstadt Román, C.J. Psychometric Properties of the Spanish Adaptation of the Health Care Communication Questionnaire (HCCQ). Span. J. Psychol. 2015, 18, E96. [Google Scholar] [CrossRef]
- World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 2013, 310, 2191–2194. [Google Scholar] [CrossRef]
- Gobierno de España Ley Orgánica 3/2018, de 5 de Diciembre, de Protección de Datos Personales y Garantía de Los Derechos Digitales. Available online: https://www.boe.es/buscar/doc.php?id=BOE-A-2018-16673 (accessed on 3 July 2019). BOE.Es—Documento BOE-A-2018-16673.
- Lovakov, A.; Agadullina, E.R. Empirically Derived Guidelines for Effect Size Interpretation in Social Psychology. Eur. J. Soc. Psychol. 2021, 51, 485–504. [Google Scholar] [CrossRef]
- Catalan-Matamoros, D.; Lopez-Villegas, A.; Lappegård, K.T.; Lopez-Liria, R. Assessing Communication during Remote Follow-Up of Users with Pacemakers in Norway: The NORDLAND Study, a Randomized Trial. Int. J. Environ. Res. Public Health 2020, 17, 7678. [Google Scholar] [CrossRef]
- Catalan-Matamoros, D.; Lopez-Villegas, A.; Costa, C.L.; Bautista-Mesa, R.; Robles-Musso, E.; Perez, P.R.; Lopez-Liria, R. A non-randomized clinical trial to examine patients’ experiences and communication during telemonitoring of pacemakers after five years follow-up. PLoS ONE 2021, 16, e0261158. [Google Scholar] [CrossRef]
- Cottrell, E.; McMillan, K.; Chambers, R. A Cross-Sectional Survey and Service Evaluation of Simple Telehealth in Primary Care: What Do Patients Think? BMJ Open 2012, 2, e001392. [Google Scholar] [CrossRef] [Green Version]
- Verhoeven, F.; Tanja-Dijkstra, K.; Nijland, N.; Eysenbach, G.; van Gemert-Pijnen, L. Asynchronous and Synchronous Teleconsultation for Diabetes Care: A Systematic Literature Review. J. Diabetes Sci. Technol. 2010, 4, 666–684. [Google Scholar] [CrossRef] [PubMed]
- Yeroushalmi, S.; Millan, S.H.; Nelson, K.; Sparks, A.; Friedman, A.J. Patient Perceptions and Satisfaction with Teledermatology During the COVID-19 Pandemic: A Survey-Based Study. J. Drugs Dermatol. JDD 2021, 20, 178–183. [Google Scholar] [CrossRef] [PubMed]
- Miller, J.; Jones, E. Shaping the Future of Teledermatology: A Literature Review of Patient and Provider Satisfaction with Synchronous Teledermatology during the COVID-19 Pandemic. Clin. Exp. Dermatol. 2022, in press. [Google Scholar] [CrossRef] [PubMed]
- Mason, A.N. The Most Important Telemedicine Patient Satisfaction Dimension: Patient-Centered Care. Telemed. J. e-Health Off. J. Am. Telemed. Assoc. 2022, 28, 1206–1214. [Google Scholar] [CrossRef] [PubMed]
- Catalan-Matamoros, D.; Lopez-Villegas, A.; Tore-Lappegard, K.; Lopez-Liria, R. Patients’ experiences of remote communication after pacemaker implant: The NORDLAND study. PLoS ONE 2019, 14, e0218521. [Google Scholar] [CrossRef]
- Agha, Z.; Roter, D.L.; Schapira, R.M. An Evaluation of Patient-Physician Communication Style During Telemedicine Consultations. J. Med. Internet Res. 2009, 11, e1193. [Google Scholar] [CrossRef]
- Edison, K.E.; Fleming, D.A.; Nieman, E.L.; Stine, K.; Chance, L.; Demiris, G. Content and Style Comparison of Physician Communication in Teledermatology and In-Person Visits. Telemed. J. e-Health Off. J. Am. Telemed. Assoc. 2013, 19, 509–514. [Google Scholar] [CrossRef]
- Stevenson, P.; Finnane, A.R.; Soyer, H.P. Teledermatology and Clinical Photography: Safeguarding Patient Privacy and Mitigating Medico-Legal Risk. Med. J. Aust. 2016, 204, 198–200. [Google Scholar] [CrossRef]
- Gómez Arias, P.J.; Abad Arenas, E.; Arias Blanco, M.C.; Redondo Sánchez, J.; Galán Gutiérrez, M.; Vélez García-Nieto, A.J. Medical and Legal Aspects of the Practice of Teledermatology in Spain. Actas Dermosifiliogr. 2021, 112, 127–133. [Google Scholar] [CrossRef]
- Edison, K.E.; Ward, D.S.; Dyer, J.A.; Lane, W.; Chance, L.; Hicks, L.L. Diagnosis, Diagnostic Confidence, and Management Concordance in Live-Interactive and Store-and-Forward Teledermatology Compared to in-Person Examination. Telemed. J. e-Health Off. J. Am. Telemed. Assoc. 2008, 14, 889–895. [Google Scholar] [CrossRef]
- Marchell, R.; Locatis, C.; Burges, G.; Maisiak, R.; Liu, W.-L.; Ackerman, M. Comparing High Definition Live Interactive and Store-and-Forward Consultations to In-Person Examinations. Telemed. J. e-Health Off. J. Am. Telemed. Assoc. 2017, 23, 213–218. [Google Scholar] [CrossRef] [PubMed]
- Nordal, E.J.; Moseng, D.; Kvammen, B.; Løchen, M.L. A Comparative Study of Teleconsultations versus Face-to-Face Consultations. J. Telemed. Telecare 2001, 7, 257–265. [Google Scholar] [CrossRef] [PubMed]
- Manary, M.P.; Boulding, W.; Staelin, R.; Glickman, S.W. The Patient Experience and Health Outcomes. N. Engl. J. Med. 2013, 368, 201–203. [Google Scholar] [CrossRef] [PubMed]
- Catalán-Matamoros, D.; López-Villegas, A. Telehealth and the current society: Challenges and opportunities. Rev. Esp. Comun. Salud 2016, 7, 336–345. [Google Scholar] [CrossRef]
Items | Possible Answers |
---|---|
Q1. Did the clinicians talk to you in a way that was easy to understand? | 1 = Not at all; 2 = To a small extent; 3 = To a moderate extent; 4 = To a large extent; 5 = To a very large extent |
Q2. Do you have confidence in the clinicians’ professional skills? | |
Q3. Did you get sufficient information about your diagnosis/afflictions? | |
Q4. Did you perceive the treatment as adapted to your situation? | |
Q5. Were you involved in decisions regarding your treatment? | |
Q6. Did you perceive the institution’s work as well organized? | |
Q7. Did you have to wait before you were admitted for services at the institution? | |
Q8. Overall, was the help and treatment you received at the institution satisfactory? | |
Q9. Overall, what benefit have you had from the care at the institution? | |
Q10. Do you believe that you were in any way given incorrect treatment? * | |
Q11. I was asked questions in an aggressive manner * | 1 = Nothing; 2 = A little; 3 = Quite a bit; 4 = A lot; 5 = Very much |
Q12. I was given answers in an aggressive manner * | |
Q13. I was treated with kindness | |
Q14. I was treated in a rude and hasty manner * | |
Q15. The healthcare provider addressed me with a smile | |
Q16. The healthcare provider was able to manage the consultation | |
Q17. The healthcare provider showed respect for my privacy |
All | Groups | p-Value | ||
---|---|---|---|---|
Teledermatology (n = 225) | Face-to-Face Dermatology (n = 225) | |||
Age M(SD) | 52.16 (19.97) | 52.53 (18.17) | 51.78 (21.65) | 0.744 a |
Women n (%) | 240 (53.3%) | 131 (58.2%) | 109 (48.4%) | 0.047 b |
Race/ethnicity n (%) | ||||
White/Caucasian | 415 (92.22%) | 208 (94.4%) | 207 (92%) | 0.453 b |
Gypsy | 6 (1.33%) | 4 (1.78%) | 2 (0.89%) | |
Hispanic/Latino | 10 (2.22%) | 5 (2.22%) | 5 (2.22%) | |
Black | 3 (0.67%) | 0 (0%) | 3 (1.33%) | |
Arab | 16 (3.56%) | 8 (3.56%) | 8 (3.56%) | |
Reason for consultation n (%) | ||||
Injury | 232 (51.56%) | 140 (62.22%) | 92 (40.89%) | 0.000 b |
Rash | 52 (11.56%) | 24 (10.67%) | 28 (12.44%) | |
Injury and rash | 14 (3.11%) | 8 (%) | 6 (2.67%) | |
Others * | 152 (33.78%) | 53 (23.56%) | 99 (44%) | |
Diagnostic tests performed n (%) | ||||
None | 363 (80.67%) | 211 (93.78%) | 152 (67.56%) | 0.000 b |
Blood test | 31 (6.89%) | 7 (3.11%) | 24 (10.67%) | |
Biopsy | 52 (11.56%) | 6 (2.67%) | 46 (20.44%) | |
Micro punctures | 3 (0.67%) | 1 (0.44%) | 2 (0.89%) | |
Anatomical location of the skin problem n (%) | ||||
Trunk | 83 (18.5%) | 41 (18.2%) | 42 (18.8%) | 0.336 b |
Limbs | 93 (20.7%) | 42 (18.7%) | 51 (22.8%) | |
Head and neck | 210 (46.8%) | 113 (50.2%) | 97 (43.3%) | |
Limbs. head and neck | 13 (2.9%) | 6 (2.7%) | 7 (3.1%) | |
Trunk and limbs | 24 (5.3%) | 14 (6.2%) | 10 (4.5%) | |
Whole body | 10 (2.2%) | 5 (2.2%) | 5 (2.2%) | |
Trunk. head and neck | 16 (3.6%) | 4 (1.8%) | 12 (5.4%) | |
Treatment n (%) | ||||
Pharmacological | 246 (54.7%) | 146 (64.9%) | 100 (44.4%) | 0.000 b |
Surgical | 123 (27.3%) | 31 (13.8%) | 92 (40.9%) | |
Follow-up and evolution | 55 (12.2%) | 45 (20%) | 10 (4.4%) | |
Pharmacological. surgical and follow-up | 26 (5.8%) | 3 (1.3%) | 23 (10.2%) | |
Number of Primary Care visits M (SD) | 1.96 (0.76) | 2.24 (0.65) | 1.68 (0.76) | 0.000 a |
Number of hospital visits M (SD) | 0.75 (0.95) | 0.01 (0.09) | 1.48 (0.85) | 0.000 a |
Basic health zones n (%) | ||||
El Ejido | 185 (41.11%) | 122 (54.22%) | 63 (28%) | 0.000 b |
Adra | 46 (10.22%) | 29 (12.89%) | 17 (7.56%) | |
Vícar | 35 (7.78%) | 9 (4%) | 26 (11.56%) | |
Roquetas de Mar | 150 (33.33%) | 62 (27.56%) | 88 (39.11%) | |
Berja | 34 (7.56%) | 3 (1.33%) | 31 (13.78%) | |
Time required for assistance n (%) | ||||
<1 h | 15 (3.3) | 15 (6.7) | 0 (0) | 0.000 b |
1–2 h | 164 (36.4) | 160 (71.1) | 4 (1.8) | |
2–3 h | 241 (53.6) | 49 (21.8) | 192 (85.3) | |
3–4 h | 30 (6.7) | 1 (0.4) | 29 (12.9) | |
>4 h | 0 (0) | 0 (0) | 0 (0) | |
Transportation used n (%) | ||||
Public transport | 39 (8.7) | 16 (7.1) | 23 (10.2) | 0.000 b |
Own car | 247 (54.9) | 97 (43.1) | 150 (66.7) | |
Ambulance | 51 (11.3) | 17 (7.6) | 34 (15.1) | |
Taxi | 9 (2) | 3 (1.3) | 6 (2.7) | |
Other | 104 (23.1) | 92 (40.9) | 12 (5.3) | |
Patient’s employment status n (%) | ||||
Working | 156 (34.7) | 89 (39.6) | 67 (29.8) | 0.005 b |
Unemployed | 94 (20.9) | 53 (23.6) | 41 (18.2) | |
Pensioner | 143 (31.8) | 66 (29.3) | 77 (34.2) | |
Sick leave | 11 (2.4) | 4 (1.8) | 7 (3.1) | |
Other | 46 (10.2) | 13 (5.8) | 33 (14.7) | |
Needs to be accompanied n (%) | ||||
No | 166 (36.9) | 100 (44.4) | 66 (29.3) | 0.001 b |
Yes | 284 (63.1) | 125 (55.6) | 159 (70.7) | |
Accompanying employment n (%) | ||||
Working | 72 (24.9) | 30 (22.7) | 42 (26.8) | 0.022 b |
Unemployed | 140 (48.4) | 57 (43.2) | 83 (52.9) | |
Pensioner | 67 (23.2) | 37 (28) | 30 (19.1) | |
Sick leave | 4 (1.4) | 2 (1.5) | 2 (1.3) | |
Other | 6 (2.1) | 6 (4.5) | 0 (0) | |
Travel expenses n (%) | ||||
No | 74 (16.4) | 51 (22.7) | 23 (10.2) | 0.000 b |
Yes | 376 (83.6) | 174 (77.3) | 202 (89.8) | |
Calls to Primary Care/Hospital n (%) | ||||
Never | 365 (81.1) | 183 (81.3) | 182 (80.9) | 0.988 b |
1 | 49 (10.9) | 24 (10.7) | 25 (11.1) | |
2 | 36 (8) | 18 (8) | 18 (8) | |
More than 2 times | 0 (0) | 0 (0) | 0 (0) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Leal-Costa, C.; Lopez-Villegas, A.; Perez-Heredia, M.; Baena-Lopez, M.A.; Hernandez-Montoya, C.J.; Lopez-Liria, R. Patients’ Experiences and Communication with Teledermatology versus Face-to-Face Dermatology. J. Clin. Med. 2022, 11, 5528. https://doi.org/10.3390/jcm11195528
Leal-Costa C, Lopez-Villegas A, Perez-Heredia M, Baena-Lopez MA, Hernandez-Montoya CJ, Lopez-Liria R. Patients’ Experiences and Communication with Teledermatology versus Face-to-Face Dermatology. Journal of Clinical Medicine. 2022; 11(19):5528. https://doi.org/10.3390/jcm11195528
Chicago/Turabian StyleLeal-Costa, Cesar, Antonio Lopez-Villegas, Mercedes Perez-Heredia, Miguel Angel Baena-Lopez, Carlos Javier Hernandez-Montoya, and Remedios Lopez-Liria. 2022. "Patients’ Experiences and Communication with Teledermatology versus Face-to-Face Dermatology" Journal of Clinical Medicine 11, no. 19: 5528. https://doi.org/10.3390/jcm11195528
APA StyleLeal-Costa, C., Lopez-Villegas, A., Perez-Heredia, M., Baena-Lopez, M. A., Hernandez-Montoya, C. J., & Lopez-Liria, R. (2022). Patients’ Experiences and Communication with Teledermatology versus Face-to-Face Dermatology. Journal of Clinical Medicine, 11(19), 5528. https://doi.org/10.3390/jcm11195528